mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.7 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |